STOPCAP M1
Menu
  • Home
  • What is STOPCAP M1?
    • Systematic reviews
      • The FAME approach
      • Docetaxel
      • Zoledronic acid
      • Abiraterone
      • Prostate RT
      • Network
    • Surrogate outcomes
      • ICECAP M0
    • Repository of patient data
  • Who is running STOPCAP M1?
    • Programme Management Group
    • International Advisory Group
    • Key Collaborators
    • Collaborative Group
  • Patient & Public Involvement
    • PPI and STOPCAP M1
    • Recent STOPCAP M1 results
    • Prostate Cancer Resources
  • News
  • Sitemap

Protocol

Protocol

Systematic review and individual participant data meta-analyses of systemic treatments for hormone-sensitive metastatic prostate cancer

 

Statistical Analysis Plan

Pairwise and network meta-analysis of individual participant data of the effects of systemic therapies for hormone-sensitive metastatic prostate cancer

  1. Home
  2. Protocol

STOPCAP M1

MRC Clinical Trials Unit at UCL
90 High Holborn
2nd Floor
London
WC1V 6LJ

Email. mrcctu.stopcapm1@ucl.ac.uk

Twitter. https://twitter.com/MRCCTU

Quick links

  • Publications
  • Protocol
Funded by PCUK

Prostate Cancer UK is a registered charity in England and Wales (1005541) and in Scotland (SC039332). Registered company 02653887.
  • © 2023
  • Sitemap
  • Cookies
  • RSS
  • Page last updated: 30-Mar-2023 15:30